Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-04-01 Sale |
2025-04-02 6:48 pm |
Terns Pharmaceuticals Inc. | TERN | Kuriakose Emil Chief Medical Officer |
952 | $2.4851 | $2,366 | 53,317 (Direct) |
View |
2024-11-30 Purchase |
2025-02-03 7:28 pm |
Terns Pharmaceuticals Inc. | TERN | Jung Melita Sun Chief Business Officer |
2,250 | $5.11 | $11,498 | 327,250 (Direct) |
View |
2024-11-30 Purchase |
2025-02-03 7:25 pm |
Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer |
510 | $5.11 | $2,606 | 1,094,609 (Direct) |
View |
2025-01-02 Sale |
2025-01-06 7:30 pm |
Terns Pharmaceuticals Inc. | TERN | Kuriakose Emil Chief Medical Officer |
4,481 | $5.7146 | $25,607 | 54,269 (Direct) |
View |
2025-01-02 Sale |
2025-01-06 7:30 pm |
Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. Chief Financial Officer |
17,188 | $5.7612 | $99,024 | 74,752 (Direct) |
View |
2025-01-02 Sale |
2025-01-06 7:30 pm |
Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director |
15,000 | $5.764 | $86,460 | 0 (Direct) |
View |
2024-12-05 Purchase |
2024-12-09 6:04 pm |
Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer |
15,450 | $7.15 | $110,468 | 19,099 (Direct) |
View |
2024-09-12 Purchase |
2024-09-17 7:48 pm |
Terns Pharmaceuticals Inc. | TERN | Lu Hongbo Director |
476,190 | $10.5 | $4,999,995 | 476,190 (Indirect) |
View |
2024-09-10 Sale |
2024-09-12 6:10 pm |
Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. Chief Financial Officer |
10,000 | $11 | $110,000 | 146,940 (Direct) |
View |
2024-09-09 Sale |
2024-09-11 6:00 pm |
Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director |
17,235 | $10 | $172,350 | 15,000 (Direct) |
View |
2024-08-01 Sale |
2024-08-05 8:11 pm |
Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director |
15,000 | $7.572 | $113,580 | 15,000 (Direct) |
View |
2024-07-15 Sale |
2024-07-17 8:53 pm |
Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner |
56,164 | $10 | $561,640 | 755,635 (Indirect) |
View |
2024-07-15 Sale |
2024-07-17 8:48 pm |
Terns Pharmaceuticals Inc. | TERN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Asia GP III L.P. OrbiMed Advisors III Ltd OrbiMed Genesis GP LLC Director 10% Owner |
56,164 | $10 | $561,640 | 755,635 (Indirect) |
View |
2024-07-15 Sale |
2024-07-17 7:56 pm |
Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director |
14,765 | $10 | $147,660 | 64,870 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-02-24 Option Award |
2025-02-25 6:12 pm |
N/A 2035-02-23 |
Terns Pharmaceuticals Inc. | TERN | Gengos Andrew Chief Financial Officer |
750,000 | $0 | 750,000 (Direct) |
View |
2025-02-20 Option Award |
2025-02-24 6:05 pm |
N/A 2035-02-19 |
Terns Pharmaceuticals Inc. | TERN | Azelby Robert Director |
90,000 | $0 | 90,000 (Direct) |
View |
Ownership |
2025-02-11 6:06 pm |
N/A N/A |
Terns Pharmaceuticals Inc. | TERN | Strauss David Eric Principal Accounting Officer |
0 | $0 | 237,173 (Direct) |
View |
2025-02-01 Option Award |
2025-02-03 7:37 pm |
N/A 2035-01-31 |
Terns Pharmaceuticals Inc. | TERN | Lu Hongbo Director |
10,657 | $0 | 10,657 (Direct) |
View |
2025-02-01 Option Award |
2025-02-03 7:36 pm |
N/A 2035-01-31 |
Terns Pharmaceuticals Inc. | TERN | Tripuraneni Radhika Director |
10,657 | $0 | 10,657 (Direct) |
View |
2025-02-01 Option Award |
2025-02-03 7:35 pm |
N/A 2035-01-31 |
Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director |
10,657 | $0 | 10,657 (Direct) |
View |
2025-02-01 Option Award |
2025-02-03 7:31 pm |
N/A 2035-01-31 |
Terns Pharmaceuticals Inc. | TERN | KINDLER JEFFREY B Director |
10,657 | $0 | 10,657 (Direct) |
View |
2025-02-01 Option Award |
2025-02-03 7:30 pm |
N/A 2035-01-31 |
Terns Pharmaceuticals Inc. | TERN | FELLOWS DAVID A Director |
18,650 | $0 | 18,650 (Direct) |
View |
2025-01-30 Option Award |
2025-02-03 7:28 pm |
N/A 2035-01-29 |
Terns Pharmaceuticals Inc. | TERN | Jung Melita Sun Chief Business Officer |
325,000 | $0 | 327,250 (Direct) |
View |
2025-01-30 Option Award |
2025-02-03 7:27 pm |
N/A 2035-01-29 |
Terns Pharmaceuticals Inc. | TERN | Kuriakose Emil Chief Medical Officer |
485,000 | $0 | 485,000 (Direct) |
View |
2025-01-30 Option Award |
2025-02-03 7:25 pm |
N/A 2035-01-29 |
Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer |
1,075,000 | $0 | 1,094,609 (Direct) |
View |
2024-12-12 Option Award |
2024-12-16 6:26 pm |
N/A 2034-12-11 |
Terns Pharmaceuticals Inc. | TERN | Kuriakose Emil Chief Medical Officer |
120,000 | $0 | 120,000 (Direct) |
View |
2024-11-18 Option Award |
2024-11-19 6:30 pm |
N/A 2034-11-17 |
Terns Pharmaceuticals Inc. | TERN | Turner Heather D Director |
64,000 | $0 | 64,000 (Direct) |
View |
2024-09-10 Exercise |
2024-09-12 6:10 pm |
N/A N/A |
Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. Chief Financial Officer |
10,000 | $5.36 | 146,940 (Direct) |
View |
2024-09-10 Exercise |
2024-09-12 6:10 pm |
N/A 2032-01-25 |
Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. Chief Financial Officer |
10,000 | $0 | 146,940 (Direct) |
View |
2024-09-09 Exercise |
2024-09-11 6:00 pm |
N/A N/A |
Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director |
17,235 | $1.82 | 15,000 (Direct) |
View |
2024-09-09 Exercise |
2024-09-11 6:00 pm |
2023-06-12 2032-06-15 |
Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director |
17,235 | $0 | 15,000 (Direct) |
View |
2024-07-15 Exercise |
2024-07-17 7:56 pm |
N/A N/A |
Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director |
14,765 | $1.82 | 64,870 (Direct) |
View |
2024-07-15 Exercise |
2024-07-17 7:56 pm |
2023-06-12 2032-06-15 |
Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director |
14,765 | $0 | 64,870 (Direct) |
View |
2024-07-01 Option Award |
2024-07-02 6:38 pm |
N/A 2034-06-30 |
Terns Pharmaceuticals Inc. | TERN | Tripuraneni Radhika Director |
4,676 | $0 | 4,676 (Direct) |
View |
2024-07-01 Option Award |
2024-07-02 6:37 pm |
N/A 2034-06-30 |
Terns Pharmaceuticals Inc. | TERN | Taylor Ann Elizabeth Director |
4,676 | $0 | 4,676 (Direct) |
View |
2024-07-01 Option Award |
2024-07-02 6:36 pm |
N/A 2034-06-30 |
Terns Pharmaceuticals Inc. | TERN | Lu Hongbo Director |
4,676 | $0 | 4,676 (Direct) |
View |
2024-07-01 Option Award |
2024-07-02 6:36 pm |
N/A 2034-06-30 |
Terns Pharmaceuticals Inc. | TERN | KINDLER JEFFREY B Director |
4,676 | $0 | 4,676 (Direct) |
View |
2024-07-01 Option Award |
2024-07-02 6:36 pm |
N/A 2034-06-30 |
Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner |
4,676 | $0 | 4,676 (Direct) |
View |
2024-07-01 Option Award |
2024-07-02 6:36 pm |
N/A 2034-06-30 |
Terns Pharmaceuticals Inc. | TERN | FELLOWS DAVID A Director |
8,183 | $0 | 8,183 (Direct) |
View |
2024-06-10 Option Award |
2024-06-14 6:05 pm |
N/A 2034-06-09 |
Terns Pharmaceuticals Inc. | TERN | Tripuraneni Radhika Director |
32,000 | $0 | 32,000 (Direct) |
View |
2024-06-10 Option Award |
2024-06-14 6:05 pm |
N/A 2034-06-09 |
Terns Pharmaceuticals Inc. | TERN | Taylor Ann Elizabeth Director |
32,000 | $0 | 32,000 (Direct) |
View |
2024-06-10 Option Award |
2024-06-14 6:04 pm |
N/A 2034-06-09 |
Terns Pharmaceuticals Inc. | TERN | Lu Hongbo Director |
32,000 | $0 | 32,000 (Direct) |
View |
2024-06-10 Option Award |
2024-06-14 6:04 pm |
N/A 2034-06-09 |
Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director |
32,000 | $0 | 32,000 (Direct) |
View |
2024-06-10 Option Award |
2024-06-14 6:04 pm |
N/A 2034-06-09 |
Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner |
32,000 | $0 | 32,000 (Direct) |
View |
2024-06-10 Option Award |
2024-06-14 6:04 pm |
N/A 2034-06-09 |
Terns Pharmaceuticals Inc. | TERN | KINDLER JEFFREY B Director |
32,000 | $0 | 32,000 (Direct) |
View |